Explore more publications!

STEM Review Turks & Caicos: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Review Turks & Caicos.

Press releases published on November 14, 2025

BTCS Reports Record Revenue for the Third Quarter 2025
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights 
Digital Identity and Biometric Access Management Provider BIO-key Reports Q3 Results; Highlights Enhanced Post Quarter Balance Sheet to Support 2026 Growth Goals; Holds Investor Call 10am ET Today
Snail Inc.’s Wandering Wizard Highlights Publishing Strategy Following Rebel Engine Launch
Vocodia Holdings Corp. Launches AI-Driven MVA Lead Generation Campaign in Partnership with Tort-X and Scale Agile Solutions
AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth
The Money Wave 2025 | Lunch "Money Wave Deep Theta Soundwave frequency Audio Manifestation 7-Minute Tesla Ritual Attracts Money
Pix to approach 8 billion monthly transactions as it marks five-year milestone, EBANX study finds
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Synaptics to Participate at Upcoming Investor Conference Wednesday, November 19, 2025
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025
reAlpha to Host Live Video Call on X Spaces to Discuss Third Quarter 2025 Results
Wrap and K-Form Strengthen Made in America Supply Chain for Wrap’s Non-Lethal Response and CUAS Manufacturing
Roadzen Reports $13.7 Million Second Quarter Revenue, a 15.2% Improvement Over Prior Year Quarter, and Fifth Consecutive Quarter of Adjusted EBITDA Improvement
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
QIDI Max4: Flagship Large-Scale 3D Printer Debuts at Formnext 2025 in Germany
Viewbix Refines Proposed Quantum X Labs Acquisition Terms – Reduces Initial Equity to 40%
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery
Communiqué de presse : Teizeild, un médicament Sanofi, a reçu l’approbation du CHMP pour une autorisation de mise sur le marché dans l’UE chez les patients atteints de diabète de type 1 de stade 2

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions